S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mistras Group Announces Record Results for Second Quarter FY'15 (2015/1/7)|
|MISTRAS Group Announces Conference Call to Discuss Fiscal 2015 Second Quarter Results on January 8, 2015 (2014/12/19)|
|MISTRAS Group Awarded Multiyear Inspection Services Contract by PSEG Nuclear LLC (2015/1/13)|
|MISTRAS-METCO Ranks Number One in the U.S. With New Nondestructive Evaluation Laboratory (2015/2/9)|
|Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis (2014/12/10)|
|Lipocine Announces Positive Phase 1b Top-Line Results With LPCN 1107 in Pregnant Women (2015/1/12)|
|Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS) (2014/12/4)|
|All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57 (2015/2/9)|
|Conatus Announces Top-Line Results From ACLF and Organ Impairment Clinical Trials of Emricasan (2015/1/8)|
|Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at the American Society of Hematology Annual Meeting (2014/12/9)|
Click above to view more mutual fund data and stats for mg - Mistras Group Inc.